Background: Our objective was to assess individual and joint relationships between various mesoscale indicators of brain health (e.g., neuronal, metabolic, and vascular integrity) and cognitive function.

Method: We used 7224 timepoint measures originating from 1825 participants of the ADNI study who were cognitively healthy or with mild cognitive impairment at initial assessment. Cognitive function outcomes were test results on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), the Rey auditory Verbal Learning Test immediate recall (RAVLTi), the Rey auditory Verbal Learning Test delayed recall (RAVLTd), the Trail Making Test A (Trail a), and the Trail Making Test B (Trail b) tasks. Four families of markers were used. First were three families of mesoscale neuroimaging assessed by MRI for 88 brain regions: 1. Neuronal integrity was estimated by FreeSurfer 6.0 produced volumes extracted from T1-weighted (T1w) images; 2. Neurite integrity was estimated through T1w/T2-weighted MRI ratios; 3. Cerebral metabolism integrity was measured by synthetic fluorodeoxyglucose-positron emission tomography, generated by a model based on a latent-space regularized generative adversarial net from T1w MRIs. Secondly, 4. Systemic markers of vascular health-related factors were included in the model (history of cardiovascular diseases, alcohol abuse, smoking history, systolic and diastolic blood pressure, history of hypertension, type 2 diabetes, Hachinski score). Cross-sectional and future cognitive outcomes were all predicted in a single machine learning model using all combinations of predictor families at baseline, time interval between outcomes and baseline as long as sex and education. Three types of regression models were tested (Ridge, Partial Least Squares and Support Vector).

Result: Individually, neuronal and metabolism integrity were the best predictors of cognitive function (Fig1; R2: .15-.35 and MAE in Z score: .08-.23). The combination of two or more mesoscale brain health markers improved predictions, with the best combination being neuronal integrity with metabolism (Figs2-3; mean R2: .28; mean MAE: .12). However, increasing the number of markers led to similar results.

Conclusion: While the prediction of cognition improved with a combination of brain health mesoscale markers, a plateau seems to be reached after combining two families.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.093687DOI Listing

Publication Analysis

Top Keywords

brain health
12
cognitive function
8
rey auditory
8
auditory verbal
8
verbal learning
8
learning test
8
trail making
8
making test
8
test trail
8
neuronal integrity
8

Similar Publications

Article Synopsis
  • A study evaluated the impacts of divalproex sodium on brain volumes in patients with mild to moderate Alzheimer’s disease using MRI scans over 24 months.
  • The results indicated that participants receiving divalproex experienced a significantly higher decline in hippocampal and brain volumes compared to those on placebo, along with a faster decline in cognitive function as measured by the Mini-Mental State Examination.
  • The findings suggest that divalproex treatment is linked to accelerated brain volume loss and potentially increased cognitive impairment, although the long-term effects remain unclear.
View Article and Find Full Text PDF
Article Synopsis
  • The study tested whether divalproex sodium (valproate) could prevent or delay agitation and psychosis in individuals with moderate Alzheimer's disease, enrolling 313 participants.
  • After two years of treatment, results showed no significant difference between the valproate and placebo groups regarding the time to development of agitation or psychosis.
  • Additionally, the valproate group experienced more side effects and showed greater reductions in brain volume, indicating potential adverse effects of the treatment.
View Article and Find Full Text PDF

Objective: To delineate the trajectories of Aβ42 level in cerebrospinal fluid (CSF), fludeoxyglucose F18 (FDG) uptake using positron emission tomography, and hippocampal volume using magnetic resonance imaging and their relative associations with cognitive change at different stages in aging and Alzheimer disease (AD).

Design: Cohort study.

Setting: The 59 study sites for the Alzheimer's Disease Neuroimaging Initiative.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!